Amgen upgraded to "neutral"

03.03.07 - Credit Suisse

NEW YORK, March 3 (newratings.com) - In a research note published yesterday, analysts at Credit Suisse upgrade Amgen Inc (AMGN) from "underperform" to "neutral." The target price is set to $63.